These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 16965861)
1. A wake-up call: are degenerative diseases provoked by some of our normal food constituents? A case for nutrigenomics. Andersen MT; Søndergaard I Med Hypotheses; 2007; 68(1):229-30. PubMed ID: 16965861 [No Abstract] [Full Text] [Related]
3. Alzheimer research forum live discussion: non-coding RNAs in neurodegeneration. J Alzheimers Dis; 2009; 16(2):441-4. PubMed ID: 19221433 [No Abstract] [Full Text] [Related]
4. Genome health nutrigenomics and nutrigenetics--diagnosis and nutritional treatment of genome damage on an individual basis. Fenech M Food Chem Toxicol; 2008 Apr; 46(4):1365-70. PubMed ID: 17693008 [TBL] [Abstract][Full Text] [Related]
5. Prefilament tau species as potential targets for immunotherapy for Alzheimer disease and related disorders. Kayed R; Jackson GR Curr Opin Immunol; 2009 Jun; 21(3):359-63. PubMed ID: 19482462 [TBL] [Abstract][Full Text] [Related]
6. Interaction between genes and environment in neurodegenerative diseases. Elbaz A; Dufouil C; Alpérovitch A C R Biol; 2007 Apr; 330(4):318-28. PubMed ID: 17502288 [TBL] [Abstract][Full Text] [Related]
7. [Alzheimer's disease and methylenetetrahydrofolate reductase gene polymorphisms: a potential nutrigenomic approach for Mexico]. Castillo-Quan JI; Pérez-Osorio JM Gac Med Mex; 2009; 145(2):147-50. PubMed ID: 19518022 [TBL] [Abstract][Full Text] [Related]
8. Vitamin E in neurodegenerative diseases. Khan HM; Saeed M J Coll Physicians Surg Pak; 2004 Jun; 14(6):386. PubMed ID: 15233901 [No Abstract] [Full Text] [Related]
9. Challenges of supplementary treatment for neurodegenerative diseases. Matsuo M Brain Dev; 2012 Feb; 34(2):85-6. PubMed ID: 22075185 [No Abstract] [Full Text] [Related]
10. Genes and the environment in neurodegeneration. Coppedè F; Mancuso M; Siciliano G; Migliore L; Murri L Biosci Rep; 2006 Oct; 26(5):341-67. PubMed ID: 17029001 [TBL] [Abstract][Full Text] [Related]
11. Blood-based proteomics for personalized medicine: examples from neurodegenerative disease. Goldknopf IL Expert Rev Proteomics; 2008 Feb; 5(1):1-8. PubMed ID: 18282116 [No Abstract] [Full Text] [Related]
12. Gene-environment interactions in non-cancer degenerative diseases. Izzotti A Mutat Res; 2009 Jul; 667(1-2):1-3. PubMed ID: 19520093 [No Abstract] [Full Text] [Related]
16. [CSF biomarkers: proteomics investigations and clinical applications in neurodegenerative disorders]. Gabelle A; Roche S; Lehmann S Rev Neurol (Paris); 2009 Mar; 165(3):213-22. PubMed ID: 18808768 [TBL] [Abstract][Full Text] [Related]
17. Role of proteomics in nutrigenomics and nutrigenetics. Kussmann M Expert Rev Proteomics; 2009 Oct; 6(5):453-6. PubMed ID: 19811066 [No Abstract] [Full Text] [Related]
18. [Childhood feeding, chronic-degenerative disease in adults, and nutrigenomics]. Caramia G Pediatr Med Chir; 2007; 29(6):309-20. PubMed ID: 18410060 [TBL] [Abstract][Full Text] [Related]
19. Your brain on diabetes. More signs that insulin ills set off neurodegenerative conditions. Wenner M Sci Am; 2008 Jun; 298(6):26, 28. PubMed ID: 18642534 [No Abstract] [Full Text] [Related]
20. +10 T/C polymorphisms in the gene of transforming growth factor-beta1 are associated with neurodegeneration and its clinical evolution. Arosio B; Bergamaschini L; Galimberti L; La Porta C; Zanetti M; Calabresi C; Scarpini E; Annoni G; Vergani C Mech Ageing Dev; 2007 Oct; 128(10):553-7. PubMed ID: 17889927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]